Adcytherix

French tech company | Builders Republic

About

Clinical-stage biopharma developing next-generation antibody-drug conjugates against hard-to-treat solid tumors — pairing targeting antibodies with novel cancer-killing payloads, with a lead candidate in early-stage human trials, built by the team that founded and sold Emergence Therapeutics to Eli Lilly.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2024
City
MARSEILLE
Region
Provence-Alpes-Côte d’Azur
Tracked rounds
1
Amount raised
105 M€ raised since 2020

Funding rounds

  • Series A — 2025

Investors